2025 Spring International Convention of
The Pharmaceutical Society of Korea

2025 Spring
International Convention of PSK

04.21(MON) - 04.22(TUE)
D+25

Abstracts

P5-8

Pathogen-derived MARTX Toxin promotes thrombosis via red blood cell activation

  • Han Young Chung*1
  • 1College of Pharmacy, Chungnam National University, Korea

Pathogens causing severe septicemia often lead to life-threatening complications such as hemolytic anemia and venous thrombosis, but the underlying mechanisms remain unclear. Here, we investigate how Vibrio vulnificus infection, at sub-hemolytic levels, induces critical alterations in human red blood cells (RBCs). These alterations include morphological transformations to echinocytes and spherocytes, externalization of phosphatidylserine (PS), and generation of microvesicles. These changes collectively enhance RBC procoagulant activity, promoting thrombin generation and RBC aggregation, which are key processes in venous thrombosis. The multifunctional autoprocessing repeats-in-toxin (MARTX) toxin, encoded by the rtxA gene of V. vulnificus, is significantly upregulated upon exposure to RBCs. Genetic deletion of rtxA eliminates these procoagulant effects, highlighting the MARTX toxin\'s essential role. Further analyses reveal that MARTX toxin-mediated pore formation leads to increased intracellular calcium levels, activating caspase-3 and scramblase, and consequently facilitating PS exposure. These findings were validated in vivo using a rat venous thrombosis model, confirming the pivotal role of MARTX toxin in thrombus formation. Our study provides novel insights into pathogen-induced thrombosis and offers potential therapeutic targets for managing infection-associated coagulopathies.


Q&A

작성하기
  • There are no registered questions
TODAY 2025. 05. 17

2025 Spring Convention

D+25

Conference infomation

Conference Schedule
Apr. 21(Mon) ~ 22(Tue), 2025
Conference Venue
Daegu Exhibition & Convention Center (EXCO) 10 Exco-ro, Buk-gu, Daegu, Republic of Korea
Location
Early Registration Period
Feb. 24(Mon) ~ Apr. 14(Mon), 2025
Abstract Submission Period
Feb. 24(Mon) ~ Apr. 3(Thu), 2025
Certificate of Attendance